| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5846816 | Toxicology and Applied Pharmacology | 2011 | 7 Pages |
Abstract
⺠Subjects with p53 Pro/Pro or MDM2 GG genotype significantly increased RCC risk. ⺠A significant multiplicative joint effect of p53 and p21 on RCC risk. ⺠RCC patients with p53 Arg/Arg genotype had efficient arsenic methylation capacity. ⺠Joint effect of p53 or MDM2 genotype and high urinary total arsenic on RCC risk.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Chao-Yuan Huang, Chien-Tien Su, Jan-Show Chu, Shu-Pin Huang, Yeong-Shiau Pu, Hsiu-Yuan Yang, Chi-Jung Chung, Chia-Chang Wu, Yu-Mei Hsueh,